LRCX vs AMAT vs TXN
161 measures in 16 categories, one definition each, computed from filings and market data.
LRCX75.7
Lam Research Corporation
Technology · Semiconductors
$263.94 −4.87%$330.3B mkt cap
Score DNA
AMAT69.4
Applied Materials, Inc.
Technology · Semiconductors
$409.29 −4.82%$324.8B mkt cap
Score DNA
TXN78.6
Texas Instruments Incorporated
Technology · Semiconductors
$276.48 −0.95%$252.5B mkt cap
Score DNA
Price, rebased to 100 three years ago
LRCX AMAT TXN · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | LRCX | AMAT | TXN |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 0 |
| Insider $ bought, 180d | — | — | — |
| Congress purchases, 180d | 0 | 14 | 2 |
| Last Congress purchase | — | 2026-08-06 | 2026-07-07 |
| 13F net change in holders | +504 | +572 | +413 |
| ETFs adding shares, 30d | 2,233 | 2,149 | 1,895 |
| ETFs trimming, 30d | 1,707 | 1,685 | 1,533 |
| Net ETF funds, 30d | +526 | +464 | +362 |
Valuation
16 measures| Measure | LRCX | AMAT | TXN |
|---|---|---|---|
| P/E (TTM) | 45.5x
49th
|
35.1x
24th
|
41.7x
39th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 2.30
50th
|
2.36
56th
|
— |
| Price / sales | 14.2x
75th
|
10.5x
57th
|
13.0x
71st
|
| Price / book | 26.5x
96th
|
12.7x
76th
|
14.0x
84th
|
| Price / tangible book | 45.2x
88th
|
20.0x
72nd
|
20.5x
73rd
|
| Price / free cash flow | 67.5x
61st
|
57.8x
52nd
|
47.2x
43rd
|
| Price / operating cash flow | 56.4x
69th
|
38.7x
50th
|
29.1x
34th
|
| Enterprise value | $328.8B
93rd
|
$322.9B
92nd
|
$259.5B
91st
|
| EV / sales | 14.2x
74th
|
10.5x
60th
|
13.3x
71st
|
| EV / EBITDA | 37.8x
61st
|
28.0x
49th
|
26.8x
44th
|
| EV / EBIT | 39.8x
55th
|
29.3x
32nd
|
34.7x
38th
|
| EV / free cash flow | 67.2x
63rd
|
57.4x
50th
|
48.5x
43rd
|
| Earnings yield | 2.2%
67th
|
2.9%
84th
|
2.4%
73rd
|
| FCF yield | 1.5%
56th
|
1.7%
63rd
|
2.1%
69th
|
| Operating cash flow yield | 1.8%
47th
|
2.6%
61st
|
3.4%
73rd
|
| Graham number (per share) | $35.80
54th
|
$91.37
88th
|
$53.82
75th
|
Profitability (TTM)
12 measures| Measure | LRCX | AMAT | TXN |
|---|---|---|---|
| Gross margin | 50.5%
57th
|
49.4%
52nd
|
58.3%
77th
|
| EBITDA margin | 37.5%
86th
|
37.4%
85th
|
49.7%
92nd
|
| Operating margin | 35.3%
89th
|
30.5%
85th
|
37.3%
93rd
|
| EBIT margin | 35.6%
86th
|
35.7%
88th
|
38.4%
92nd
|
| Net margin | 31.3%
91st
|
30.1%
87th
|
31.1%
89th
|
| NOPAT margin | 31.0%
88th
|
26.4%
83rd
|
32.7%
92nd
|
| FCF margin | 21.1%
75th
|
18.2%
68th
|
27.5%
84th
|
| Operating cash flow margin | 25.2%
71st
|
27.2%
76th
|
44.6%
95th
|
| R&D / revenue | 10.2%
24th
|
12.9%
35th
|
10.7%
27th
|
| SG&A / revenue | 4.9%
7th
|
5.4%
9th
|
9.5%
25th
|
| Stock comp / revenue | 1.7%
21st
|
2.2%
31st
|
2.8%
40th
|
| Effective tax rate | 12.1%
19th
|
13.6%
29th
|
12.4%
23rd
|
Returns on capital
11 measures| Measure | LRCX | AMAT | TXN |
|---|---|---|---|
| ROE (on average equity) | 65.1%
96th
|
41.1%
93rd
|
35.2%
91st
|
| ROA | 32.4%
97th
|
23.8%
91st
|
17.1%
83rd
|
| ROIC | 65.5%
93rd
|
34.2%
87th
|
25.4%
77th
|
| ROCE | 47.0%
97th
|
33.2%
92nd
|
22.9%
85th
|
| Return on tangible assets | 36.8%
96th
|
28.3%
91st
|
21.1%
84th
|
| Cash ROIC (OCF / invested capital) | 53.2%
95th
|
35.4%
81st
|
34.6%
79th
|
| Gross profitability (GP / assets) | 49.8%
96th
|
35.0%
73rd
|
31.6%
68th
|
| ROIC, 3-yr average | 53.3%
96th
|
37.0%
89th
|
24.2%
80th
|
| ROIC, 5-yr average | 62.6%
87th
|
51.3%
86th
|
38.8%
83rd
|
| ROE, 5-yr average | 57.1%
97th
|
41.7%
94th
|
40.9%
92nd
|
| Incremental ROIC | 126.6%
89th
|
33.2%
63rd
|
120.2%
86th
|
Growth
17 measures| Measure | LRCX | AMAT | TXN |
|---|---|---|---|
| Revenue growth (TTM YoY) | 26.0%
64th
|
7.8%
29th
|
16.7%
47th
|
| Revenue growth (QoQ) | 15.1%
56th
|
15.2%
60th
|
13.2%
49th
|
| Revenue CAGR, 3 yr | 10.1%
66th
|
5.1%
56th
|
1.1%
41st
|
| Revenue CAGR, 5 yr | 9.7%
61st
|
7.4%
52nd
|
3.0%
30th
|
| Gross profit CAGR, 3 yr | 14.7%
70th
|
7.3%
59th
|
-3.1%
33rd
|
| Operating income CAGR, 3 yr | 16.6%
75th
|
7.0%
62nd
|
-6.1%
40th
|
| Net income growth (TTM YoY) | 35.6%
51st
|
35.6%
54th
|
20.1%
37th
|
| Net income CAGR, 3 yr | 17.2%
74th
|
12.9%
69th
|
-7.7%
44th
|
| EPS growth (TTM YoY) | 37.3%
49th
|
37.5%
51st
|
19.0%
34th
|
| EPS CAGR, 3 yr | 19.7%
77th
|
14.8%
69th
|
-7.8%
44th
|
| EPS CAGR, 5 yr | 16.2%
68th
|
14.9%
59th
|
-1.7%
29th
|
| FCF growth (TTM YoY) | -14.4%
20th
|
-3.4%
33rd
|
256.3%
91st
|
| FCF CAGR, 3 yr | 1.5%
49th
|
-7.0%
34th
|
18.9%
68th
|
| Operating cash flow CAGR, 3 yr | 4.2%
54th
|
1.6%
44th
|
5.6%
58th
|
| Book value CAGR, 3 yr | 17.4%
79th
|
21.4%
81st
|
4.0%
36th
|
| Dividend CAGR, 3 yr | 5.6%
70th
|
5.8%
74th
|
1.3%
33rd
|
| Sustainable growth rate | 53.7%
94th
|
34.4%
92nd
|
5.5%
29th
|
Margin history & stability
7 measures| Measure | LRCX | AMAT | TXN |
|---|---|---|---|
| Gross margin, 3-yr average | 48.8%
57th
|
48.4%
54th
|
58.6%
81st
|
| Operating margin, 3-yr average | 32.0%
90th
|
29.9%
89th
|
36.4%
94th
|
| Net margin, 3-yr average | 28.7%
90th
|
27.2%
86th
|
31.5%
93rd
|
| FCF margin, 3-yr average | 26.9%
89th
|
21.0%
72nd
|
15.3%
61st
|
| Revenue stability (0-1) | 0.63
56th
|
0.97
96th
|
0.13
17th
|
| Earnings stability (0-1) | 0.59
72nd
|
0.75
83rd
|
0.40
56th
|
| Margin stability (0-1) | 0.95
71st
|
0.97
83rd
|
0.93
56th
|
Liquidity (latest quarter)
7 measures| Measure | LRCX | AMAT | TXN |
|---|---|---|---|
| Cash & short-term investments | $5.6B
88th
|
$9.2B
93rd
|
$7.0B
91st
|
| Net cash (− = net debt) | $1.5B
91st
|
$1.9B
93rd
|
−$7.1B
4th
|
| Working capital | $9.7B
89th
|
$14.7B
93rd
|
$12.5B
92nd
|
| Current ratio | 2.63
32nd
|
2.42
25th
|
4.86
65th
|
| Quick ratio | 1.91
33rd
|
1.79
27th
|
3.44
61st
|
| Cash ratio (cash + ST investments / current liabilities) | 0.94
25th
|
0.89
23rd
|
2.16
61st
|
| Defensive interval (days) | 1,130 days
72nd
|
1,060 days
65th
|
849 days
56th
|
Leverage & solvency (latest quarter)
13 measures| Measure | LRCX | AMAT | TXN |
|---|---|---|---|
| Total debt | $4.1B
80th
|
$7.3B
91st
|
$14.1B
95th
|
| Debt / equity | 0.33
64th
|
0.29
60th
|
0.78
84th
|
| Net debt / equity | −0.12
60th
|
−0.07
64th
|
0.39
87th
|
| Debt / assets | 17.5%
59th
|
16.9%
55th
|
39.2%
87th
|
| Debt / capital | 24.8%
64th
|
22.3%
60th
|
43.8%
84th
|
| Debt / EBITDA | 0.47
37th
|
0.64
39th
|
1.45
60th
|
| Net debt / EBITDA | −0.17
64th
|
−0.16
66th
|
0.73
80th
|
| Interest coverage (EBIT / interest) | 66.5x
81st
|
39.7x
74th
|
13.2x
52nd
|
| Cash interest coverage | 47.1x
72nd
|
30.3x
67th
|
15.4x
50th
|
| Debt payback (years of OCF) | 0.7 yrs
40th
|
0.9 yrs
43rd
|
1.6 yrs
57th
|
| Liabilities / assets | 47.0%
69th
|
41.1%
63rd
|
49.8%
79th
|
| IS credit model rating | AA+ | AA+ | AA |
| Implied credit spread (bps) | 65
0th
|
65
0th
|
80
19th
|
Efficiency
11 measures| Measure | LRCX | AMAT | TXN |
|---|---|---|---|
| Asset turnover | 1.04
97th
|
0.79
84th
|
0.55
55th
|
| Fixed asset turnover | 7.86
79th
|
4.80
53rd
|
1.63
13th
|
| Inventory turnover | 2.7
51st
|
2.5
41st
|
1.7
14th
|
| Receivables turnover | 5.3
33rd
|
4.6
23rd
|
8.7
76th
|
| Days sales outstanding | 68 days
67th
|
80 days
77th
|
42 days
24th
|
| Days inventory outstanding | 136 days
49th
|
145 days
59th
|
212 days
86th
|
| Days payables outstanding | 34 days
12th
|
49 days
48th
|
35 days
16th
|
| Cash conversion cycle (days) | 170 days
65th
|
176 days
68th
|
219 days
84th
|
| Capex / revenue | 4.2%
41st
|
9.0%
74th
|
17.0%
89th
|
| Capex / depreciation | 2.19
85th
|
5.30
99th
|
1.50
76th
|
| Operating expense ratio | 14.4%
9th
|
16.6%
16th
|
19.1%
22nd
|
Cash flow & earnings quality
7 measures| Measure | LRCX | AMAT | TXN |
|---|---|---|---|
| Operating cash flow / net income | 0.81
15th
|
0.91
25th
|
1.43
56th
|
| FCF / net income | 0.67
27th
|
0.61
17th
|
0.88
50th
|
| FCF / operating cash flow | 83.5%
67th
|
67.0%
35th
|
61.8%
32nd
|
| Capex / operating cash flow | 16.5%
33rd
|
33.0%
65th
|
38.2%
68th
|
| Accruals ratio | 6.3%
93rd
|
2.2%
85th
|
-7.4%
27th
|
| Sloan accruals ratio | 5.7%
57th
|
6.1%
59th
|
-4.8%
16th
|
| Earnings quality score (0-1) | 0.75
15th
|
0.75
15th
|
0.75
15th
|
Scores & forensic checks
15 measures| Measure | LRCX | AMAT | TXN |
|---|---|---|---|
| IS score | 76
81st
|
69
69th
|
79
88th
|
| IS profitability | 96
92nd
|
95
89th
|
95
91st
|
| IS growth | 83
88th
|
66
45th
|
69
49th
|
| IS value | 40
71st
|
38
59th
|
39
64th
|
| IS momentum | 86
64th
|
79
49th
|
92
77th
|
| IS risk (safety) | 100
12th
|
100
12th
|
100
12th
|
| IS quality | 85
87th
|
83
79th
|
88
95th
|
| IS balance sheet | 92
73rd
|
92
76th
|
84
47th
|
| IS earnings quality | 52
31st
|
61
39th
|
72
81st
|
| IS cash flow | 62
60th
|
58
48th
|
79
83rd
|
| Piotroski F-score (0-9) | 8
91st
|
6
43rd
|
7
65th
|
| Altman Z-score | 30.7
81st
|
18.3
65th
|
12.9
55th
|
| Beneish M-score | −1.70
79th
|
−2.04
68th
|
−3.06
8th
|
| Ohlson O-score | −10.54
29th
|
−10.71
25th
|
−10.03
37th
|
| IS credit score | 93
91st
|
91
83rd
|
86
64th
|
Size (TTM)
8 measures| Measure | LRCX | AMAT | TXN |
|---|---|---|---|
| Market cap | $330.3B
93rd
|
$324.8B
92nd
|
$252.5B
91st
|
| Revenue | $23.2B
91st
|
$30.8B
92nd
|
$19.5B
89th
|
| EBITDA | $8.7B
91st
|
$11.5B
95th
|
$9.7B
92nd
|
| Net income | $7.3B
93rd
|
$9.3B
96th
|
$6.1B
91st
|
| Free cash flow | $4.9B
89th
|
$5.6B
93rd
|
$5.4B
92nd
|
| Total assets | $23.5B
83rd
|
$43.5B
91st
|
$35.9B
89th
|
| Shareholders' equity | $12.5B
84th
|
$25.6B
91st
|
$18.0B
88th
|
| Employees | 23,300
83rd
|
36,500
92nd
|
33,000
89th
|
Price performance
9 measures| Measure | LRCX | AMAT | TXN |
|---|---|---|---|
| 1 day | −4.9% | −4.8% | −0.9% |
| 1 week | −17.2% | −19.3% | −2.6% |
| 1 month | −1.9% | −1.9% | +7.1% |
| 3 months | −14.0% | −22.1% | −2.2% |
| 6 months | −1.4% | +3.1% | +21.5% |
| Year to date | +42.8% | +52.4% | +58.4% |
| 1 year | +82.6% | +80.2% | +61.8% |
| 3 years, cumulative | +320.6% | +193.7% | +91.5% |
| 5 years, cumulative | +403.4% | +236.8% | +63.2% |
Technicals
4 measures| Measure | LRCX | AMAT | TXN |
|---|---|---|---|
| RSI 14 | 30.3 | 29.2 | 47.6 |
| From 52-week high | −39.8% | −44.7% | −16.8% |
| From 52-week low | +95.1% | +101.6% | +84.1% |
| Beta | 1.85 | 1.59 | 1.34 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17